CVRx Inc (NASDAQ: CVRX) on Friday, plunged -4.75% from the previous trading day, before settling in for the closing price of $5.47. Within the past 52 weeks, CVRX’s price has moved between $4.30 and $18.55.
During the last 5-year period, the sales drop of Healthcare Sector giant was -28.44%. The company achieved an average annual earnings per share of 23.52%. With a float of $15.79 million, this company’s outstanding shares have now reached $26.19 million.
CVRx Inc (CVRX) Insider Activity
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of CVRx Inc is 39.76%, while institutional ownership is 30.49%. The most recent insider transaction that took place on Nov 26 ’25, was worth 63,560. In this transaction 10% Owner of this company sold 6,337 shares at a rate of $10.03, taking the stock ownership to the 4,040,861 shares. Before that another transaction happened on Nov 24 ’25, when Company’s 10% Owner sold 2,200 for $10.06, making the entire transaction worth $22,132. This insider now owns 4,047,198 shares in total.
CVRx Inc (CVRX) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.43 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.38) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.99% during the next five years compared to -28.44% drop over the previous five years of trading.
CVRx Inc (NASDAQ: CVRX) Trading Performance Indicators
CVRx Inc (CVRX) is currently performing well based on its current performance indicators. A quick ratio of 8.60 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.02, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -1.93 in one year’s time.
